NuVasive receives FDA clearance to expand interlock device’s applications for cervical spine

The FDA recently granted NuVasive 510(k) clearance to expand its CoRent Small Interlock system for multilevel use in cervical spine surgery.

Advertisement

Four insights:

1. The CoRent device is now expanded for use at multiple adjacent levels from C2-T1 for anterior cervical discectomy and fusion procedures.

2. The device is an anterior cervical interbody fusion system intended for use in patients suffering from cervical disc degeneration and/or cervical spinal instability.

3. It is a no-profile interfixated interlock system that is implanted within the vertebral disc.

4. CoRent features a zero-step locking mechanism, a large fusion space, angled instrumentation for difficult implantation areas and a three-screw design that improves interbody placement.

More articles on devices:
19 spine devices receive FDA 510(k) clearance in October
Medtronic Q2 spine revenue up 5.5%
Orthofix M6-C cervical disc in 2019: 7 key developments  

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.